1-1 of 1
Kendra Anderson
Close
Save search
Sort by
Journal Articles

Phase I Study of Bortezomib(Bz), Pegylated Doxorubicin(DOX) and Dexamethasone(dex); ( VDD) with Escalating Doses of Cyclophosphamide(Cy) in Patients with Newly Diagnosed Myeloma.

Free
Melissa Alsina, MD, Rachid Baz, MD, Jose L Ochoa, MD, Jyotishankar Raychaudhuri, Kara Kosakowski, Michelle Mintz, Kendra Anderson, William S Dalton, M.D., Ph.D, Daniel Sullivan
Journal: Blood
Blood (2009) 114 (22): 617.
https://doi.org/10.1182/blood.V114.22.617.617
Published: 2009